Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma
Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma
About this item
Full title
Author / Creator
Publisher
New York: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Histiocytic sarcoma (HS), a rare hematological malignancy, is an aggressive neoplasm that responds poorly to therapy. The molecular etiology and pathology of this disease remain unclear, hampering the development of an effective therapy, and there remains a need for more, and more realistic, animal models. HS cells typically show a histiocytic (ie,...
Alternative Titles
Full title
Mice lacking Dok-1, Dok-2, and Dok-3 succumb to aggressive histiocytic sarcoma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_762270748
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_762270748
Other Identifiers
ISSN
0023-6837
E-ISSN
1530-0307
DOI
10.1038/labinvest.2010.121
